Know the Industry
Know the IndustryLesson 7 of 114 min

The Medical Device Companies Every New Rep Should Know

A map of the major medical device companies for new reps: the diversified giants, the robotics leader, and the diabetes specialists, with what each is known for and the real numbers.

*Publishing note for launch: every company name below (shown in bold) should link to its Vocari platform company page.*

Two moments in a new rep's life go better if you know the companies: the interview, where some version of what do you know about our space is a near-certain question, and the decision about where to build, since the company you start with shapes the next decade.

You do not need to memorize a stock screener. You need to recognize the major players and know what each is actually known for. Here is that map.

Who are the biggest medical device companies?

Start with the companies whose names come up in almost every interview.

  • Medtronic is the largest pure-play, at about $36 billion a year across cardiovascular (its biggest business, near $14 billion), neuroscience and spine, surgical, and diabetes.
  • Abbott is a $44 billion diversified health company whose medical-devices arm leads in diabetes: its FreeStyle Libre franchise makes it the global CGM leader, and its structural-heart and electrophysiology lines are major cardiovascular players.
  • Stryker sells about $25 billion across orthopedics and MedSurg, and is the name most associated with surgical robotics in ortho through Mako.
  • Johnson & Johnson MedTech spans orthopedics, surgery, vision, and cardiovascular, and is a top-two orthopedics company through DePuy Synthes.

These four come up constantly because they are big, broad, and hire in volume. For a new rep, they are the most common source of structured associate programs.

Who leads in surgical robotics?

One name dominates: Intuitive Surgical, maker of the da Vinci system, which holds roughly 75 percent of the global robotic-surgery market on about $8 billion in annual robotics revenue. If you sell in surgery, you will encounter da Vinci.

The giants are chasing it. Medtronic's Hugo system won its first US clearance, in urology, in late 2025, and J&J's Ottava is in development. Robotics is where much of MedTech's growth and hiring is concentrated.

Who are the diabetes and CGM specialists?

Diabetes technology is one of the fastest-growing corners of the industry, and two focused companies anchor it alongside Abbott.

  • Dexcom is a roughly $4.7 billion pure-play in continuous glucose monitoring, built on its G7 sensor and the over-the-counter Stelo biosensor. It leads the US CGM market.
  • MiniMed, the roughly $3 billion diabetes business spun out of Medtronic in 2026, makes the MiniMed 780G automated insulin-delivery system and has more than 640,000 pump users worldwide.

CGM is a high-growth, high-frequency sale, and these names come up whenever the conversation turns to diabetes or wearables.

Which challengers are worth watching?

Beyond the incumbents, a new rep should know the industry still produces fast-rising challengers. SS Innovations, maker of the lower-cost SSi Mantra surgical robot, grew revenue more than 100 percent in its latest year and filed for US clearance in late 2025. It is a reminder that even robotics, dominated by one giant, has room for new entrants.

Knowing a challenger or two signals to an interviewer that you follow the industry, not just the household names. It also points to where open territories and ground-floor opportunities tend to appear.

Key Takeaways

  • Recognizing the major device companies helps in interviews and in choosing where to build a career.
  • The diversified giants are Medtronic (about $36B), Abbott (about $44B), Stryker (about $25B), and J&J MedTech.
  • Intuitive Surgical leads surgical robotics with roughly 75 percent global share; Medtronic and J&J are chasing.
  • Dexcom and MiniMed anchor the fast-growing diabetes and CGM space alongside Abbott.
  • Challengers like SS Innovations show even dominated categories still make room for new entrants.

Frequently Asked Questions

What are the biggest medical device companies?

Among pure-play device makers, Medtronic is the largest at about $36 billion a year, followed by Stryker at about $25 billion and Johnson & Johnson MedTech. Abbott is a larger diversified health company at about $44 billion whose device arm leads in diabetes. These names anchor most conversations in the industry.

Which medical device companies should a new rep know?

Start with the diversified giants (Medtronic, Abbott, Stryker, J&J MedTech), the surgical-robotics leader Intuitive Surgical, and the diabetes specialists Dexcom and MiniMed. Knowing a fast-rising challenger like SS Innovations helps too. Together they cover the specialties and technology trends interviewers ask about.

What is the largest area of medical device sales?

Cardiovascular is one of the largest single segments; it is Medtronic's biggest business at about $14 billion. Orthopedics is another giant, with its top ten companies selling more than $46 billion combined. Diabetes and surgical robotics are among the fastest-growing areas.

Do I need to know company financials for a medical sales interview?

You do not need exact figures, but you should be able to speak to what each major company is known for, roughly how big it is, and where the industry is heading, especially robotics and diabetes technology. That level of fluency signals genuine interest and separates you from applicants who only know the brand names.

  • The Best Orthopedic Device Companies to Work For
  • The 2026 Medical Sales Salary Guide
  • How to Break Into Medical Device Sales With No Experience

About This Series

This guide is part of Vocari Intelligence, The Lobby’s series on how the medical sales business actually works, built from company financials and market data.

Not sure which company fits you? Set your parameters once on [Vocari](https://www.myvocari.com) and see roles matched to the specialty and level you want.

Sources _No indexed sources cited._